Related Experiment Video
Updated: Jun 30, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
Cognitive impairment and structural brain damage in benign multiple sclerosis
M Rovaris1, G Riccitelli, E Judica
1Neuroimaging Research Unit, Department of Neurology, Scientific Institute and University Ospedale San Raffaele, Milan, Italy.
Objective:
Although in benign multiple sclerosis (BMS) locomotor disability is absent or only minimal, subclinical cognitive impairment seems to occur in many cases. Diffusion tensor (DT) MRI enables us to quantify the extent of "actual" tissue damage, which goes undetected when using conventional MRI. Against this background, we investigated the extent of structural brain damage underlying cognitive dysfunction in BMS, with the ultimate aim to move a first step toward a more reliable definition of this disease phenotype.
Methods:
Conventional and DT MRI scans of the brain were acquired from 62 BMS patients. Thirty-six secondary progressive multiple sclerosis (SPMS) patients and 19 healthy subjects served as controls. In BMS patients, neuropsychological tests exploring memory, attention, and frontal lobe functions were administered. Normalized brain volume (NBV), mean diffusivity (MD), and fractional anisotropy (FA) of the normal-appearing white matter (NAWM) and MD of the gray matter (GM) were computed.
Results:
Twelve BMS patients (19%) fulfilled predefined criteria for cognitive impairment. BMS patients had abnormal MD and FA values from both NAWM and GM. Whereas BMS patients without cognitive impairment had lower T2 LV (p = 0.03), higher NBV (p = 0.006), and lower average GM MD (p = 0.03) than SPMS patients, BMS patients with cognitive impairment did not significantly differ from SPMS patients for any MRI-derived metric.
Conclusions:
In benign multiple sclerosis (BMS), cognitive dysfunction is associated with severe structural brain damage, which resembles that of patients with a much more disabling disease course. A reliable definition of BMS should, therefore, include the preservation of cognitive functioning as an additional requisite.
Insights
Cognitive impairment in benign multiple sclerosis (BMS) is linked to significant brain damage, similar to more advanced disease stages. Preserving cognitive function is key to defining BMS accurately.
Area of Science:
- Neuroimaging
- Neurology
- Neuroscience
Background:
- Benign multiple sclerosis (BMS) typically presents with minimal locomotor disability but may involve subclinical cognitive impairment.
- Conventional MRI often misses subtle tissue damage, necessitating advanced techniques like Diffusion Tensor (DT) MRI.
Purpose of the Study:
- To investigate the extent of structural brain damage associated with cognitive dysfunction in BMS.
- To contribute to a more reliable definition of the BMS disease phenotype.
Main Methods:
- Conventional and DT MRI scans were performed on 62 BMS patients, 36 secondary progressive multiple sclerosis (SPMS) patients, and 19 healthy controls.
- Neuropsychological tests assessed memory, attention, and frontal lobe functions in BMS patients.
- Metrics included normalized brain volume (NBV), mean diffusivity (MD), and fractional anisotropy (FA) in normal-appearing white matter (NAWM) and gray matter (GM).
Main Results:
- 19% of BMS patients met criteria for cognitive impairment.
- BMS patients exhibited abnormal MD and FA values in both NAWM and GM.
- BMS patients with cognitive impairment showed no significant difference in MRI metrics compared to SPMS patients, unlike those without cognitive impairment.
Conclusions:
- Cognitive dysfunction in BMS correlates with severe structural brain damage, comparable to patients with more debilitating MS.
- The preservation of cognitive function should be an essential criterion for defining BMS.
Related Concept Videos
Multiple Sclerosis l: Introduction
Dementia l: Introduction
Alzheimer Disease ll: Pathophysiology
Secondary Spinal Cord Injury llI: Pathophysiology
Cerebral Edema ll: Pathophysiology

